AzTrials
AzTrials

Diplegic Cerebral PalsyNCT05223257

Action Observation in Children With Diplegic Cerebral Palsy

A study testing AOT in people with Diplegic Cerebral Palsy, run by IRCCS Fondazione Stella Maris at 3 sites in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A new rehabilitative approach, called AOT, based on the discovery of mirror neuron system (MNS), has been used with promising results on the Upper Limb (UL) function in some studies in children with Cerebral Palsy (CP). Read more about this study

Who is it for?
Ages 5 to 16 years
Conditions the study is for
Diplegic Cerebral Palsy
What is being tested?
AOT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
3 sitesItaly
Study dates
1 Jun 2022to 16 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • diagnosis of diplegic cerebral palsy (DCP) (GMFCS level I to IV - children may have been achieved an independent gait)
  • age between 5 and 16 years
  • MACS level I-IV
  • sufficient cooperation and communicative understanding to perform assessments and participate in the intervention
  • caregivers able to commit and collaborate in a rehabilitative intensive home
  • subjects and parents able to commit to the intensive rehabilitation program for a period of 8 weeks.

Who cannot join

  • Exclusion criteria will be uncontrolled seizures and UL botulinum injections or orthopaedic surgery in the previous 6 months or during the study period.

Trial locations and contacts

3 sites in 1 country.

Giuseppina Sgandurra, Dr. contact

+393392472874

g.sgandurra@fsm.unipi.it

Italy3 sites
  • University of Parma

    Parma, 43125

  • IRCCS Fondazione Stella Maris

    Pisa, 56128

  • IRCCS Reggio Emilia

    Reggio Emilia, 42122

Other trials in Italy

About this study

Official title: Action Observation Tele-rehabilitation for Upper Limb in Children With Diplegic Cerebral Palsy

A new rehabilitative approach, called AOT, based on the discovery of mirror neuron system (MNS), has been used with promising results on the Upper Limb (UL) function in some studies in children with Cerebral Palsy (CP).

The purpose of the present trial is to provide evidence by an RCT, preceded by a pilot study, that customized and home based AOT training is an effective rehabilitation tool in children with diplegic CP (DCP) and that its effects are greater than standard care.

Both Hands Assessment (BoHA) is chosen as primary outcome measure and a sample size of 27 per group is required. The rehabilitation lasting 8 weeks will be provided at home by an ICT platform able to deliver, manage, monitor and measure a personalized AOT.

Read the detailed description

A two-arm, evaluator-blinded, randomized trial (RCT), preceded by a pilot study, will be conducted according to CONSORT guidelines. Each participant will be randomized to either:

  1. Intervention group (Experimental group). Children will receive immediately the system for 8 weeks.
  2. Standard care group (Control group). Children will continue standard care At the end of the project, if the study results will be positive, children enrolled in the control group will be able to have the same treatment as the experimental group, if necessary.

The system will provide an in-home, individualized, intensive treatment based on the AOT. The system will be delivered at home and the children will perform a 60-minute training session at least 5 days a week for 8 consecutive weeks (total of 40 hours).

Follow-up assessment (outcome measures) will be conducted before (T0) and post-intervention at 1 weeks (T1), and then 8 and 24 weeks after the AOT intervention/standard care (T2 and T3).

The primary endpoint will be T1. Clinical assessments will be administered by a therapist blind to group assignment in each centre. Scoring of videotaped clinical outcome measures will be performed by therapists blind to group allocation and assessment order.

Being tested
AOT
Keywords
Tele-rehabilitation, Action Observation, Mirror neurons, ICT
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AOTOther

    Observation of video sequences showing unimanual and bimanual goal-directed actions followed by the execution of the observed actions with upper limbs for unimanual and bimanual actions.

Study groups in NCT05223257
Study groupRoleWhat they receive
Experimental groupExperimentalAOT is based on the observation of meaningful actions followed by their execution
Receives: Other: AOT
Control groupNo interventionChildren will continue standard care for 8 weeks Subject allocated to "standard care" group will have to continue what they normally do; they (if > 13 years) or their parents will have to fill a diary in which they will write the rehabilitative activities they do, specifying their intensity and whether these activities are more focused on the lower limbs or upper limbs.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in the Both Hands Assessment (BoHA)

    This assessment measures bimanual performance in children with bilateral CP, during a semi-structured session with specific toys or activities.

    Measured: Baseline (T0, 1 week before beginning of the study); T1 (within 1 week after the end of the training/control period); T2 (8 weeks after the end of the training/control period) and T3 (24 weeks after the end of the training/control period)

Secondary outcomes (18)
  1. Changes in Melbourne Assessment 2 (MA2)

    It is criterion-referenced test that measures unilateral upper extremity quality of movement in subjects with neurological impairments.

    Measured: Baseline (T0, 1 week before beginning of the study); T1 (within 1 week after the end of the training/control period); T2 (8 weeks after the end of the training/control period) and T3 (24 weeks after the end of the training/control period)

  2. Changes in Box and Block Test (BBT)

    It measures unilateral gross manual dexterity. It is a quick, simple and inexpensive test. It can be used with a wide range of populations from childhood to adults.

    Measured: Baseline (T0, 1week before beginning of the study); T1 (within 1 week after the end of the training/control period); T2 (8 weeks after the end of the training/control period) and T3 (24 weeks after the end of the training/control period)

  3. Changes in cognitive assessment

    It will be done cognitive assessment with the Wechsler Intelligence Scale for Children (WISC) that is an individually administered intelligence test for children.

    Measured: Baseline (T0, 1 week before beginning of the study)

  4. Changes in neuropsychological assessment (social perception domain)

    It will be done neuropsychological assessment with NEPSY-2 social perception domains, that measures the ability to: understand social contexts, interpret non verbal communication, form impressions of others, use contextual information to make inferences about others and their behaviour.

    Measured: Baseline (T0, 1 week before beginning of the study)

  5. Changes in neuropsychological assessment (sensory-motor domain)

    It will be done neuropsychological assessment with NEPSY-2 sensory-motor domains, that consists of four tests that evaluate motor speed and precision, the ability to plan and execute movement sequences, bimanual and visuomotor coordination and imitation of movement.

    Measured: Baseline (T0, 1 week before beginning of the study); T1 (within 1 week after the end of the training/control period); T3 (24 weeks after the end of the training/control period)

  6. Changes in BRIEF P

    The Behavior Rating Inventory of Executive Function (BRIEF) measures the executive function in daily life context of children from the parents point of view. BRIEF P is for pre-school children.

    Measured: Baseline (T0, 1 week before beginning of the study); T1 (within 1 week after the end of the training/control period); T3 (24 weeks after the end of the training/control period)

  7. Changes in BRIEF 2

    The Behavior Rating Inventory of Executive Function (BRIEF) measures the executive function in daily life context of children from the parents point of view. BRIEF 2 is for school children.

    Measured: Baseline (T0, 1 week before beginning of the study); T1 (within 1 week after the end of the training/control period); T3 (24 weeks after the end of the training/control period)

  8. Changes in ABILHAND-kids

    A semi-structured item-response questionnaire that measures manual ability according to a caregiver's perceived difficulty performing daily bimanual tasks.

    Measured: Baseline (T0, 1week before beginning of the study); T1 (within 1 week after the end of the training/control period); T2 (8 weeks after the end of the training/control period) and T3 (24 weeks after the end of the training/control period)

  9. Changes in Cerebral Palsy Quality of Life Questionnaire for Children (CP QOL -Child, 4-12 years)

    This instrument is useful for evaluating interventions designed to improve the lives of children.

    Measured: Baseline (T0) and T3 (24 weeks after the end of the training/control period)

  10. Changes in Cerebral Palsy Quality of Life Questionnaire for Adolescents (CP QOL -Teen, 13-18 years)

    This instrument is useful for evaluating interventions designed to improve the lives of adolescents.

    Measured: Baseline (T0) and T3 (24 weeks after the end of the training/control period)

  11. Changes in Participation and Environment Measure - Children and Youth (PEM-CY)

    It is a measure that evaluates participation in the home, at school, and in the community, alongside environmental factors within each of these settings.

    Measured: Baseline (T0) and T3 (16 weeks after T2)

  12. Changes in Canadian occupational performance measure (COPM)

    It is a validated measure that aims to identify rehabilitation needs in daily life and changes by the subject or his family.

    Measured: Baseline (T0, 1week before beginning of the study); T1 (within 1 week after the end of the training/control period); T2 (8 weeks after the end of the training/control period) and T3 (24 weeks after the end of the training/control period)

  13. Changes in technological measurement of manual abilities by means of Virtual Reality Rehabilitation System (VRRS)

    VRRS activities are aimed at estimating and evaluating the uni and bimanual activities, quantitatively through kinematic parameters.

    Measured: Baseline (T0, 1week before beginning of the study); T1 (within 1 week after the end of the training/control period); T2 (8 weeks after the end of the training/control period) and T3 (24 weeks after the end of the training/control period)

  14. Changes in technological measurement of manual abilities by means of Upper Limb TRAcker system (ULTRA +)

    ULTRA+ is a sensorized biomechatronic system equipped with an articulated arm with seven degrees of freedom. Kinematic and grip strength parameters will be obtained, thanks to a real immersion in a three-dimensional virtual environment.

    Measured: Baseline (T0, 1week before beginning of the study); T1 (within 1 week after the end of the training/control period); T2 (8 weeks after the end of the training/control period) and T3 (24 weeks after the end of the training/control period)

  15. Feasibility questionnaire

    In order to investigate the feasibility of the system and the compliance of children and their families, will be carried out a questionnaire ad hoc at the end of the T1 assessment training in the experimental group.

    Measured: T1 (within 1 week after the end of the training)

  16. Changes in cerebral plasticity with fMRI (Functional Magnetic Resonance Imaging)

    A subgroup of children, selected based on specific inclusion sub-criteria, will be asked to perform the fMRI examination before (T0) and immediately after the end of the experimental or standard treatment period (T1). The children will perform two tasks:

    1. Motor execution
    2. Action observation task In order to understand the feasibility of these tasks and the brain circuits involved during their execution, a group of typically developing children and healthy young adults will also be enrolled on a voluntary basis.

    The fMRI study will evaluate the difference in intensity and extension of brain activation in relation to the rehabilitation intervention, as well as to demonstrate the effectiveness of the experimental rehabilitation intervention compared to the control one.

    Measured: Baseline (T0, 1week before beginning of the study); T1 (within 1 week after the end of the training/control period)

  17. Quantitative Changes in upper limbs activities detected with Actigraph GXT3+ during clinical assessment.

    Actigraph GXT3+ worn during BoHA assessments

    Measured: Baseline (T0, 1week before beginning of the study); T1 (within 1 week after the end of the training/control period); T2 (8 weeks after the end of the training/control period) and T3 (24 weeks after the end of the training/control period)

  18. Changes in daily life activities detected with Actigraph GXT3+

    Quantitative measurement of daily manual activities

    Measured: During training and/or standard period (from T0 to T1) (T0, 1 week before beginning of the study); T1 (within 1 week after the end of the training/control period)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2022
  2. Study start1 Jun 2022 (estimated)
  3. Primary completion16 Jun 2025 (estimated)
  4. Study completion16 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
It will be a parallel RCT
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
54 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05223257
Sponsor's protocol ID
RF-2019-12370746
Status last verified
Mar 2022
First submitted
17 Dec 2021
Last updated
31 Mar 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Sgandurra G, Ferrari A, Cossu G, Guzzetta A, Biagi L, Tosetti M, Fogassi L, Cioni G. Upper limb children action-observation training (UP-CAT): a randomised controlled trial in hemiplegic cerebral palsy. BMC Neurol. 2011 Jun 28;11:80. doi: 10.1186/1471-2377-11-80.

    PubMed 21711525
  • Buchignani B, Beani E, Pomeroy V, Iacono O, Sicola E, Perazza S, Bieber E, Feys H, Klingels K, Cioni G, Sgandurra G. Action observation training for rehabilitation in brain injuries: a systematic review and meta-analysis. BMC Neurol. 2019 Dec 27;19(1):344. doi: 10.1186/s12883-019-1533-x.

    PubMed 31881854
  • Sgandurra G, Cecchi F, Beani E, Mannari I, Maselli M, Falotico FP, Inguaggiato E, Perazza S, Sicola E, Feys H, Klingels K, Ferrari A, Dario P, Boyd RN, Cioni G. Tele-UPCAT: study protocol of a randomised controlled trial of a home-based Tele-monitored UPper limb Children Action observation Training for participants with unilateral cerebral palsy. BMJ Open. 2018 May 14;8(5):e017819. doi: 10.1136/bmjopen-2017-017819.

    PubMed 29764869
  • Beani E, Menici V, Ferrari A, Cioni G, Sgandurra G. Feasibility of a Home-Based Action Observation Training for Children With Unilateral Cerebral Palsy: An Explorative Study. Front Neurol. 2020 Feb 28;11:16. doi: 10.3389/fneur.2020.00016. eCollection 2020.

    PubMed 32180754
  • Sgandurra G, Biagi L, Fogassi L, Ferrari A, Sicola E, Guzzetta A, Tosetti M, Cioni G. Reorganization of action observation and sensory-motor networks after action observation therapy in children with congenital hemiplegia: A pilot study. Dev Neurobiol. 2020 Sep;80(9-10):351-360. doi: 10.1002/dneu.22783. Epub 2020 Oct 28.

    PubMed 32986904

Questions about this trial

What is this clinical trial studying?

A study testing AOT in people with Diplegic Cerebral Palsy, run by IRCCS Fondazione Stella Maris at 3 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Giuseppina Sgandurra, Dr. (+393392472874, g.sgandurra@fsm.unipi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in the Both Hands Assessment (BoHA) (time frame: Baseline (T0, 1 week before beginning of the study); T1 (within 1 week after the end of the training/control period); T2 (8 weeks after the end of the training/control period) and T3 (24 weeks after the end of the training/control period)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05223257, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in